- Home
- AVTX vs SMWB Comparison
AVTX vs SMWB Comparison
Compare AVTX & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | SMWB |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | Israel |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 778.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVTX | SMWB |
|---|---|---|
| Price | $12.14 | $8.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $44.08 | $10.83 |
| AVG Volume (30 Days) | ★ 959.1K | 486.6K |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | N/A | $11.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $12.51 | $2.22 |
| 52 Week High | $24.27 | $9.50 |
Technical Indicators
Market Signals| Indicator | AVTX | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 22.50 | 57.60 |
| Support Level | N/A | $7.83 |
| Resistance Level | $20.54 | $9.18 |
| Average True Range (ATR) | 0.84 | 0.46 |
| MACD | -0.17 | 0.10 |
| Stochastic Oscillator | 1.24 | 71.29 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.